A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

In an effort to combat Alzheimer's disease, scientists are looking at existing drugs that could treat the condition, and a ...

New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

This week’s XBI pullback is healthy. Biotech stocks cannot go up every day. The sector’s recovery off the April lows has been ...

Cognition Therapeutics, Inc. ( ($CGTX) ) has released its Q3 earnings. Here is a breakdown of the information Cognition Therapeutics, Inc.

A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...

Esther Landhuis is a journalist in the San Francisco Bay Area. She holds a Ph.D. in immunology and covers biomedicine in all dimensions, from bench discoveries to biotech to health care. Alzheimer’s ...